Gene · 3455
Papers3,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The influence of genetic polymorphisms on cytokine profiles in pediatric COVID-19: a pilot study. | Front Pediatr | 2025 | 40066463 | PubTator, text mining | PubMed |
| The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomes. | Nat Genet | 2025 | 40038547 | PubTator, text mining | PubMed |
| β-hydroxybutyrylation and O-GlcNAc modifications of STAT1 modulate antiviral defense in aging. | Cell Mol Immunol | 2025 | 39979583 | PubTator, text mining | PubMed |
| Protein kinase a suppresses antiproliferative effect of interferon-α in hepatocellular carcinoma by activation of protein tyrosine phosphatase SHP2. | J Biol Chem | 2025 | 39826687 | PubTator, text mining | PubMed |
| Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity. | J Clin Invest | 2025 | 39817453 | PubTator, text mining | PubMed |
| Cullin-5 controls the number of megakaryocyte-committed stem cells to prevent thrombocytosis in mice. | Blood | 2025 | 39791603 | PubTator, text mining | PubMed |
| IFN alpha signaling drives hematopoietic stem cells malfunction under acute inflammation. | Int Immunopharmacol | 2025 | 39764994 | PubTator, text mining | PubMed |
| Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity. | PLoS One | 2025 | 39752416 | PubTator, text mining | PubMed |
| A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity. | J Exp Med | 2025 | 39680367 | PubTator, text mining | PubMed |
| Association study of the JAK/STAT signaling pathway with susceptibility to COVID-19 in moroccan patient and in-silico analysis of rare variants. | Virus Res | 2025 | 39647533 | PubTator, text mining | PubMed |
| Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus. | Nat Rev Rheumatol | 2025 | 39623155 | PubTator, text mining | PubMed |
| Adjusting susceptibilities of C57BL/6 mice to orthoflaviviruses for evaluation of antiviral drugs by altering the levels of interferon alpha/beta receptor function. | J Virol Methods | 2025 | 39426414 | PubTator, text mining | PubMed |
| Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality. | Nucleosides Nucleotides Nucleic Acids | 2025 | 38660988 | PubTator, text mining | PubMed |
| Genetic Basis for Mucormycosis Progression in COVID-19 Patients: From Susceptibility to Severity. | Infect Dis Immun | 2024 | 42325292 | PubTator, text mining | PubMed |
| Regulation of human interferon signaling by transposon exonization. | Cell | 2024 | 39672162 | PubTator, text mining | PubMed |
| Expression of Toll-like Receptor Genes and Antiviral Cytokines in Macrophage-like Cells in Response to Indole-3-carboxylic Acid Derivative. | Viruses | 2024 | 39599833 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis and in vivo validation of potential immune-related genes linked to diabetic nephropathy. | Heliyon | 2024 | 39583850 | PubTator, text mining | PubMed |
| Recombinant soluble type I interferon receptor exerts antiviral activity by inducing proteins related to autophagy. | Biomed Pharmacother | 2024 | 39577364 | PubTator, text mining | PubMed |
| Promiscuous Janus kinase binding to cytokine receptors modulates signaling efficiencies and contributes to cytokine pleiotropy. | Sci Signal | 2024 | 39561221 | PubTator, text mining | PubMed |
| Severe Adverse Reaction to Measles Vaccine Due to Homozygous Mutation in the IFNAR2 Gene: A Case Report and Literature Review. | J Clin Immunol | 2024 | 39436454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3455/papers?page=6